SAGE THERAPEUTICS INC Call options
Reported by Decagon Asset Management LLP
First reported at 292,000 underlying shares controlled this quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2025-06-30 | 2663040 |
| 2025-09-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Underlying shares | Change | % of reported 13F | Reported notional value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2025 | Reduced | 0 | -292,000 (-100.0%) | 0 | $0 | 2025-11-14 | |
| Q2 2025 | New | 292,000 | +292,000 (0.0%) | 1.74% | $2,663,040 | 2025-08-14 |
Who else reported the position
11 managers reported SAGE THERAPEUTICS INC for Q2 2025.
| Manager | Activity | Underlying shares | Change | % of reported 13F | Reported notional value | Tenure |
|---|---|---|---|---|---|---|
| Decagon Asset Management LLP This report | New | 292,000 | +292,000 | 1.74% | $2,663,040 | 1 qtr |
| MILLENNIUM MANAGEMENT LLC | New | 154,500 | +154,500 | < 0.01% | $1,409,040 | 1 qtr |
| Hudson Bay Capital Management LP | New | 97,500 | +97,500 | < 0.01% | $889,200 | 1 qtr |
| SUSQUEHANNA INTERNATIONAL GROUP LLP | Reduced | 62,200 | -24,700 | < 0.01% | $567,264 | 41 qtrs |
| Walleye Trading LLC | New | 37,900 | +37,900 | < 0.01% | $345,648 | 1 qtr |
| Walleye Capital LLC | New | 28,500 | +28,500 | < 0.01% | $259,920 | 1 qtr |
| Caption Management LLC | Unchanged | 25,000 | 0 | < 0.01% | $228,000 | 10 qtrs |
| CITADEL ADVISORS LLC | Reduced | 23,200 | -1,800 | < 0.01% | $211,584 | 36 qtrs |
| WOLVERINE TRADING LLC | New | 18,500 | +18,500 | < 0.01% | $169,275 | 4 qtrs |
| JANE STREET GROUP LLC | New | 13,200 | +13,200 | < 0.01% | $120,384 | 1 qtr |
Filing details and methodology As reported
- Report period
- June 30, 2025
- Filed
- August 14, 2025
- Filing type
- 13F-HR
- Position type
- Call options
Voting authority reported
- Sole
- 292,000
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.